Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2014-12-11
Target enrollment:
Participant gender:
Summary
This trial is conducted globally. The aim of the trial is to examine the dose range,
escalation and efficacy of oral semaglutide in subjects with type 2 diabetes.